![Enoch Kariuki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Enoch Kariuki
Directeur/Membre du Conseil chez
ZENTALIS PHARMACEUTICALS, INC.
Fortune : 943 155 $ au 30/06/2026
Profil
Enoch K.
Kariuki is currently Vice President at H.I.G.
BioHealth Partners LLC, Independent Director at Zentalis Pharmaceuticals, Inc. since 2021, Director at ProfoundBio US Co. since 2024, and President at Endeavor BioMedicines, Inc. since 2024.
Former roles include Co-Chief Executive Officer & Director at Lengo Therapeutics, Inc., Associate Director at UBS AG (New York), Independent Director at Imago BioSciences, Inc. from 2020 to 2023, Director at Biocom, Inc., Principal at CVS Health Corp., Senior Associate at Leerink Partners LLC, Senior Vice President-Corporate Development at Synthorx, Inc. from 2018 to 2020, and Chief Financial Officer at VelosBio, Inc. from 2020 to 2021.
Education includes a doctorate from Texas Southern University and an MBA from Tuck School of Business at Dartmouth.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 194 465 ( 0,27% ) | 943 155 $ | 30/06/2026 |
Postes actifs de Enoch Kariuki
| Sociétés | Poste | Début |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 09/02/2021 |
H.I.G. BioHealth Partners LLC
 H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners invests in companies located in the United States. The firm targets companies operating in the field of medical devices, biopharmaceuticals, digital health, tool & diagnostics and product related services. It provides financing for acquisition, IPO and growth stage capital requirements in the form of equity and debt. It also makes follow on investments. | Private Equity Investor | - |
Endeavor BioMedicines, Inc
 Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage company that develops hedgehog inhibitor for Idiopathic pulmonary fibrosis | President | 14/03/2024 |
Anciens postes connus de Enoch Kariuki
| Sociétés | Poste | Fin |
|---|---|---|
| IMAGO BIOSCIENCES, INC. | Directeur/Membre du Conseil | 11/01/2023 |
VelosBio, Inc.
 VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research activities | Directeur Financier/CFO | 01/01/2021 |
| SYNTHORX, INC. | Corporate Officer/Principal | 01/02/2020 |
Lengo Therapeutics, Inc.
 Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops small molecule precision therapeutics that target driver mutations in oncology | Directeur Général | - |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Directeur/Membre du Conseil | - |
Formation de Enoch Kariuki
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
CVS Health Corp.
 CVS Health Corp. Drugstore ChainsRetail Trade Operates as a holding company whose subsidiaries provides health, pharmacy and consumer wellness services | Retail Trade |
UBS AG (New York)
 UBS AG (New York) Investment ManagersFinance UBS Private Banking employs asset allocation methods to manage separate portfolios based on each client's investment objectives and risk tolerance. | Finance |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Texas Southern University
 Texas Southern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
H.I.G. BioHealth Partners LLC
H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners invests in companies located in the United States. The firm targets companies operating in the field of medical devices, biopharmaceuticals, digital health, tool & diagnostics and product related services. It provides financing for acquisition, IPO and growth stage capital requirements in the form of equity and debt. It also makes follow on investments. | Finance |
Synthorx, Inc.
 Synthorx, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that uses synthetic biology to discover and develop protein therapeutics | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases | Health Technology |
VelosBio, Inc.
VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research activities | Commercial Services |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Lengo Therapeutics, Inc.
Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops small molecule precision therapeutics that target driver mutations in oncology | Health Technology |
Endeavor BioMedicines, Inc
Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage company that develops hedgehog inhibitor for Idiopathic pulmonary fibrosis | Commercial Services |
